News & Updates

Show Multimedia Only
Elagolix on par with dienogest for endometriosis-related pain

Elagolix on par with dienogest for endometriosis-related pain

11 Nov 2024 byStephen Padilla

In the treatment of pain due to endometriosis, use of elagolix 150-mg tablets demonstrates comparable efficacy to dienogest 2-mg tablets, as assessed via numeric rating scale (NRS) score from baseline to day 85 and 169, according to a study presented at RCOG 2024. Additionally, both drugs are well tolerated.

Elagolix on par with dienogest for endometriosis-related pain

11 Nov 2024
Oral misoprostol solution measures up to tablet formulation for labour induction

Oral misoprostol solution measures up to tablet formulation for labour induction

08 Nov 2024
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication

Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication

08 Nov 2024

Vonoprazan-based bismuth-containing quadruple therapy (VBCQ) does better at eradicating Helicobacter pylori (H. pylori) than proton pump inhibitor (PPI)-based BCQ therapy (PBCQ), with similar adverse reactions and compliance, a study has shown.

Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication

08 Nov 2024
Menopausal hormone therapy prevents relapse in women with SSD

Menopausal hormone therapy prevents relapse in women with SSD

07 Nov 2024